123 related articles for article (PubMed ID: 3262618)
41. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
42. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
43. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.
Heaton JH; Nebes VL; O'Dell LG; Morris SM; Gelehrter TD
Mol Endocrinol; 1989 Jan; 3(1):185-92. PubMed ID: 2536889
[TBL] [Abstract][Full Text] [Related]
44. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
[TBL] [Abstract][Full Text] [Related]
45. The effect of phorbol esters and diacylglycerol on expression of the phosphoenolpyruvate carboxykinase (GTP) gene in rat hepatoma H4IIE cells.
Chu DT; Granner DK
J Biol Chem; 1986 Dec; 261(36):16848-53. PubMed ID: 3023368
[TBL] [Abstract][Full Text] [Related]
46. On the regulation of the plasminogen activator inhibitor-1 gene expression.
Descheemaeker K
Verh K Acad Geneeskd Belg; 1993; 55(3):225-64. PubMed ID: 8342330
[TBL] [Abstract][Full Text] [Related]
47. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells.
van den Berg EA; Sprengers ED; Jaye M; Burgess W; Maciag T; van Hinsbergh VW
Thromb Haemost; 1988 Aug; 60(1):63-7. PubMed ID: 2460966
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells.
Gong Y; Alkhalaf B; Murphy LJ; Murphy LC
Cell Growth Differ; 1992 Nov; 3(11):847-53. PubMed ID: 1467312
[TBL] [Abstract][Full Text] [Related]
49. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
Lund LR; Eriksen J; Ralfkiaer E; Rømer J
J Invest Dermatol; 1996 Apr; 106(4):622-30. PubMed ID: 8617995
[TBL] [Abstract][Full Text] [Related]
50. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.
Fattal PG; Schneider DJ; Sobel BE; Billadello JJ
J Biol Chem; 1992 Jun; 267(18):12412-5. PubMed ID: 1618746
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.
Heaton JH; Kathju S; Gelehrter TD
Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371
[TBL] [Abstract][Full Text] [Related]
52. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.
Riccio A; Lund LR; Sartorio R; Lania A; Andreasen PA; Danø K; Blasi F
Nucleic Acids Res; 1988 Apr; 16(7):2805-24. PubMed ID: 3130610
[TBL] [Abstract][Full Text] [Related]
53. Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture.
Heaton JH; Dame MK; Gelehrter TD
J Lab Clin Med; 1992 Aug; 120(2):222-8. PubMed ID: 1500822
[TBL] [Abstract][Full Text] [Related]
54. Tumor necrosis factor-alpha regulates plasminogen activator inhibitor-1 in rat testicular peritubular cells.
Le Magueresse-Battistoni B; Pernod G; Kolodié L; Morera AM; Benahmed M
Endocrinology; 1997 Mar; 138(3):1097-105. PubMed ID: 9048615
[TBL] [Abstract][Full Text] [Related]
55. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
Rehemtulla A; Gates J; Hart DA
Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
[TBL] [Abstract][Full Text] [Related]
56. Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycle.
Skouv J; Jensen PO; Forchhammer J; Larsen JK; Lund LR
Cell Growth Differ; 1994 Mar; 5(3):329-40. PubMed ID: 8018565
[TBL] [Abstract][Full Text] [Related]
57. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
Tierney MJ; Medcalf RL
J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
[TBL] [Abstract][Full Text] [Related]
58. Activation of plasminogen activator inhibitor-1 synthesis by phorbol esters in human promyelocyte HL-60--roles of PCKbeta and MAPK p42.
Lopez S; Peiretti F; Morange P; Laouar A; Fossat C; Bonardo B; Huberman E; Juhan-Vague I; Nalbone G
Thromb Haemost; 1999 Mar; 81(3):415-22. PubMed ID: 10102471
[TBL] [Abstract][Full Text] [Related]
59. Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein.
Schwartz BS; Bradshaw JD
J Biol Chem; 1992 Apr; 267(10):7089-94. PubMed ID: 1551915
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1.
DiBattista JA; Martel-Pelletier J; Morin N; Jolicoeur FC; Pelletier JP
Mol Cell Endocrinol; 1994 Jul; 103(1-2):139-48. PubMed ID: 7525383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
